Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
Tài liệu tham khảo
Asplund, 1998, Chronic mucosal changes of the colon in graft-versus-host disease, Mod. Pathol., 11, 513
Barker, 2007, Identification of stem cells in small intestine and colon by marker gene Lgr5, Nature, 449, 1003, 10.1038/nature06196
Brandl, 2009, Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response, Proc. Natl. Acad. Sci. USA, 106, 3300, 10.1073/pnas.0813036106
Breault, 2008, Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells, Proc. Natl. Acad. Sci. USA, 105, 10420, 10.1073/pnas.0804800105
Cella, 2009, A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity, Nature, 457, 722, 10.1038/nature07537
Dalle, 2008, HSCT for Fanconi anemia in children: factors that influence early and late results, Bone Marrow Transplant., 42, S51, 10.1038/bmt.2008.284
Das, 2009, Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease, Blood, 113, 2352, 10.1182/blood-2008-08-175448
Flowers, 2011, Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria, Blood, 117, 3214, 10.1182/blood-2010-08-302109
Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J. Cell Biol., 119, 493, 10.1083/jcb.119.3.493
Hill, 2000, The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation, Blood, 95, 2754, 10.1182/blood.V95.9.2754.009k25_2754_2759
Jagasia, 2012, Risk factors for acute GVHD and survival after hematopoietic cell transplantation, Blood, 119, 296, 10.1182/blood-2011-06-364265
Jasperson, 2008, Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality, Blood, 111, 3257, 10.1182/blood-2007-06-096081
Jiang, 2012, Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity, Nature, 483, 227, 10.1038/nature10851
Kabashima, 2002, The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut, J. Clin. Invest., 109, 883, 10.1172/JCI0214459
Kinnebrew, 2012, Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense, Immunity, 36, 276, 10.1016/j.immuni.2011.12.011
Kreymborg, 2007, IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis, J. Immunol., 179, 8098, 10.4049/jimmunol.179.12.8098
Liang, 2006, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, J. Exp. Med., 203, 2271, 10.1084/jem.20061308
Lin, 2003, Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation, N. Engl. J. Med., 349, 2201, 10.1056/NEJMoa022060
Medema, 2011, Microenvironmental regulation of stem cells in intestinal homeostasis and cancer, Nature, 474, 318, 10.1038/nature10212
Merad, 2004, Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease, Nat. Med., 10, 510, 10.1038/nm1038
Montgomery, 2011, Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells, Proc. Natl. Acad. Sci. USA, 108, 179, 10.1073/pnas.1013004108
Nash, 1992, Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate, Blood, 80, 1838, 10.1182/blood.V80.7.1838.1838
Okamoto, 1999, The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells, J. Hepatobiliary Pancreat. Surg., 6, 254, 10.1007/s005340050115
Penack, 2010, Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors, Blood, 115, 1865, 10.1182/blood-2009-09-242784
Petrovic, 2004, LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease, Blood, 103, 1542, 10.1182/blood-2003-03-0957
Pickert, 2009, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing, J. Exp. Med., 206, 1465, 10.1084/jem.20082683
Sangiorgi, 2008, Bmi1 is expressed in vivo in intestinal stem cells, Nat. Genet., 40, 915, 10.1038/ng.165
Sanos, 2011, Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells, Immunology, 132, 453, 10.1111/j.1365-2567.2011.03410.x
Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935
Sato, 2011, Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts, Nature, 469, 415, 10.1038/nature09637
Sawa, 2010, Lineage relationship analysis of RORgammat+ innate lymphoid cells, Science, 330, 665, 10.1126/science.1194597
Sawa, 2011, RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota, Nat. Immunol., 12, 320, 10.1038/ni.2002
Shlomchik, 2007, Graft-versus-host disease, Nat. Rev. Immunol., 7, 340, 10.1038/nri2000
Simons, 2011, Stem cell self-renewal in intestinal crypt, Exp. Cell Res., 317, 2719, 10.1016/j.yexcr.2011.07.010
Sonnenberg, 2011, Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22, Nat. Immunol., 12, 383, 10.1038/ni.2025
Sonnenberg, 2011, CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut, Immunity, 34, 122, 10.1016/j.immuni.2010.12.009
Spits, 2011, The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling, Nat. Immunol., 12, 21, 10.1038/ni.1962
Tachiiri, 2003, Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice, Genes Immun., 4, 153, 10.1038/sj.gene.6363934
Takashima, 2011, The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells, J. Exp. Med., 208, 285, 10.1084/jem.20101559
van Ampting, 2012, Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice, Infect. Immun., 80, 1115, 10.1128/IAI.06165-11
Wingard, 2011, Long-term survival and late deaths after allogeneic hematopoietic cell transplantation, J. Clin. Oncol., 29, 2230, 10.1200/JCO.2010.33.7212
Witte, 2010, Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection, Cytokine Growth Factor Rev., 21, 365, 10.1016/j.cytogfr.2010.08.002
Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007
Wolk, 2006, IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis, Eur. J. Immunol., 36, 1309, 10.1002/eji.200535503
Yan, 2009, Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis, PLoS ONE, 4, e6073, 10.1371/journal.pone.0006073
Zenewicz, 2007, Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation, Immunity, 27, 647, 10.1016/j.immuni.2007.07.023
Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature, 445, 648, 10.1038/nature05505
Zhu, 2009, Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation, Nature, 457, 603, 10.1038/nature07589